SAN DIEGO--(BUSINESS WIRE)--Mar. 2, 2012-- Illumina, Inc. (NASDAQ: ILMN) today announced that it will webcast the company's presentations at two upcoming investment conferences.
Illumina will webcast its presentation at the Cowen and Company Health Care Conference in Boston, Massachusetts, on March 7, 2012. The live webcast is scheduled to begin at 8:40 a.m. ET and will feature an overview of the company by Jay Flatley, President and Chief Executive Officer.
Illumina will also webcast its presentation at the Barclays Capital Global Healthcare Conference in Miami, Florida, on March 14, 2012. The live webcast is scheduled to begin at 10:45 a.m. ET and will feature an overview of the company by Christian Henry, Senior Vice President and GM, Genomic Solutions, followed by a question and answer session.
These webcasts can be accessed in the Investor Relations section of Illumina's web site under the "Company" tab at www.illumina.com.
About Illumina
Illumina (http://www.illumina.com) is a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. We provide innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA and protein. We also provide tools and services that are fueling advances in consumer genomics and diagnostics. Our technology and products accelerate genetic analysis research and its application, paving the way for molecular medicine and ultimately transforming healthcare.
Source: Illumina, Inc.
Illumina, Inc.
Investors:
Kevin Williams, MD
Investor Relations
858-332-4989
kwilliams@illumina.com
or
Media:
Jennifer Temple
Public Relations
858-429-8350
pr@illumina.com
